Common use of Disclosure of Shares Sold Clause in Contracts

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 167 contracts

Samples: At the Market Offering Agreement (Air Industries Group), At the Market Offering Agreement (Signing Day Sports, Inc.), At the Market Offering Agreement (electroCore, Inc.)

AutoNDA by SimpleDocs

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 47 contracts

Samples: Equity Distribution Agreement (InspireMD, Inc.), Equity Distribution Agreement (Cellectar Biosciences, Inc.), Equity Distribution Agreement (Skye Bioscience, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 21 contracts

Samples: At the Market Offering Agreement, At the Market Offering Agreement (Youngevity International, Inc.), At the Market Offering Agreement (India Globalization Capital, Inc.)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 9 contracts

Samples: Equity Distribution Agreement (Day One Biopharmaceuticals, Inc.), Equity Distribution Agreement (Prothena Corp Public LTD Co), Equity Distribution Agreement (Prothena Corp Public LTD Co)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K F and Quarterly Reports semi-annual or quarterly reports on Form 106-QK, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report report on Form 86-K or a further Prospectus Supplement.

Appears in 6 contracts

Samples: At the Market Offering Agreement (Genius Group LTD), At the Market Offering Agreement (Genius Group LTD), At the Market Offering Agreement (Guardforce AI Co., Ltd.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; , and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 5 contracts

Samples: Sales Agreement (NewAge, Inc.), At the Market Offering Agreement (Bridgeline Digital, Inc.), At the Market Offering Agreement (New Age Beverages Corp)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, Q and in its Annual Report on Form 10-K the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 5 contracts

Samples: Sales Agreement (Larimar Therapeutics, Inc.), Sales Agreement (Larimar Therapeutics, Inc.), Sales Agreement (Surrozen, Inc./De)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 4 contracts

Samples: At the Market Offering Agreement (Cleanspark, Inc.), At the Market Offering Agreement (NextPlay Technologies Inc.), At the Market Offering Agreement (Cleanspark, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 4 contracts

Samples: At the Market Offering Agreement, At the Market Offering Agreement (India Globalization Capital, Inc.), At the Market Offering Agreement (India Globalization Capital, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number amount of Placement Shares sold through the Manager under this AgreementAgents, the Net Proceeds to the Company and the compensation paid payable by the Company with respect to sales of the Agents respecting such Placement Shares pursuant to this Agreement during within the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplementperiod.

Appears in 4 contracts

Samples: At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.), At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.), At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 4 contracts

Samples: At the Market Offering Agreement (Pear Therapeutics, Inc.), At the Market Offering Agreement (Uranium Energy Corp), At the Market Offering Agreement (Opgen Inc)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager under this AgreementAgent hereunder, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to such sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 3 contracts

Samples: Equity Distribution Agreement (Aptevo Therapeutics Inc.), Equity Distribution Agreement (Aptevo Therapeutics Inc.), Equity Distribution Agreement (Aptevo Therapeutics Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company and the Trust with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 3 contracts

Samples: At the Market Offering Agreement (Air T Funding), At the Market Offering Agreement (Air T Inc), At the Market Offering Agreement (Air T Funding)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds to the Company Agreement and the compensation paid by net proceeds to the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Arvinas, Inc.), Equity Distribution Agreement (Arvinas, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplementsupplement to the Prospectus.

Appears in 2 contracts

Samples: At the Market Offering Agreement (Windtree Therapeutics Inc /De/), At the Market Offering Agreement (Windtree Therapeutics Inc /De/)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K and Quarterly Reports on Form 10-Q, as applicable, F the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarterperiod covered by the report; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report of Foreign Issuer on Form 86-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: At the Market Offering Agreement (Altamira Therapeutics Ltd.), At the Market Offering Agreement (Locafy LTD)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through or to the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: At the Market Offering Agreement (Zedge, Inc.), At the Market Offering Agreement (Zedge, Inc.)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds to the Company and the compensation paid by net proceeds to the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Fulcrum Therapeutics, Inc.), Equity Distribution Agreement (Fulcrum Therapeutics, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-F or on Form 6-K and Quarterly Reports on Form 10-Qwhen disclosing interim financial reports, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarterperiod; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: At the Market Offering Agreement (VivoPower International PLC), At the Market Offering Agreement (Aptorum Group LTD)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds to the Company Agreement and the compensation paid by net proceeds to the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Casa Systems Inc), Equity Distribution Agreement (Arvinas, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Agents under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (U.S. GoldMining Inc.)

AutoNDA by SimpleDocs

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager under this AgreementAgent hereunder, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: Equity Distribution Agreement (Alpine Immune Sciences, Inc.)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; quarter and, if required by in the case of any subsequent change in Commission policy or request, more frequently by means of a Current Report annual report on Form 810-K or a further Prospectus SupplementK, during the fourth quarter of the applicable fiscal year.

Appears in 1 contract

Samples: Equity Distribution Agreement (Nuvectra Corp)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: Equity Distribution Agreement (Biomea Fusion, Inc.)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.. ​

Appears in 1 contract

Samples: Equity Distribution Agreement (Independence Contract Drilling, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.. ​

Appears in 1 contract

Samples: At the Market Offering Agreement (ProMIS Neurosciences Inc.)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.. ​

Appears in 1 contract

Samples: Equity Distribution Agreement (Altimmune, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (Bit Digital, Inc)

Disclosure of Shares Sold. The To the extent required, the Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (General Moly, Inc)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: Equity Distribution Agreement (CVRx, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports Report on Form 1040-K F or 20-F and Quarterly Reports on Form 10-Q, as applicableits interim management’s discussion and analysis prepared and filed with the Commission, the number of Shares sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (TRX GOLD Corp)

Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.. ​

Appears in 1 contract

Samples: Equity Distribution Agreement (Sigilon Therapeutics, Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, Agreement and the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (ENDRA Life Sciences Inc.)

Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K F and Quarterly Reports on Form 106-QK, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (CYREN Ltd.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!